NCBI PubMed NLMPubMed
My NCBI
[Sign In] [Register]
All Databases PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
Limits 
Preview/Index 
History 
Clipboard 
Details 
About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
Special Queries
LinkOut
My NCBI (Cubby)

Related Resources
Order Documents
NLM Catalog
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central

 Note: 
  Performing your original search, Vaginal absorption estriol, in PubMed will retrieve 15 citations.

 Display  Show 
All: 1 
Review: 0 
1: Acta Obstet Gynecol Scand. 1983;62(5):393-6. Related Articles, Links

Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women.

Mattsson LA, Cullberg G.

In a comparative randomized cross-over study the absorption of a single dose of 0.5 mg estriol from a vaginal cream or a vaginal suppository (OvestinR, Organon, The Netherlands) was studied. Eight healthy postmenopausal women participated and the preparations were given with an interval of 14 days. Blood sampling was performed twice before application and then after 1/4, 1/2, 1, 2, 4, 6, 8, 24 and 48 hours. Serum was analysed for unconjugated and conjugated estriol (E3), FSH and LH by radio-immunoassay. Considerable interindividual variations in serum levels of unconjugated E3 were found but mean values were about equal throughout the study for the two preparations. Peak levels of 0.5-0.6 nmol/l were achieved 1-2 hours after application of the preparations and after 24 hours no unconjugated E3 was measurable. Conjugated E3 rose rapidly but within 48 hours serum concentrations reached baseline levels. A maximum decrease in serum LH levels of about 40% was obtained with both preparations after 6 hours and the return to baseline within 24 hours indicates a relationship to unconjugated E3. FSH in serum was maximally suppressed 6-12%. Estriol is thus readily absorbed by the vaginal route and peak levels of unconjugated E3 after insertion of 0.5 mg estriol seem to be comparable to those obtained after 8-12 mg estriol given orally.

Publication Types:
  • Clinical Trial
  • Randomized Controlled Trial

MeSH Terms:
  • Absorption
  • Clinical Trials
  • Comparative Study
  • Estriol/administration & dosage
  • Estriol/metabolism*
  • Female
  • Follicle Stimulating Hormone/blood
  • Humans
  • Luteinizing Hormone/blood
  • Menopause*/drug effects
  • Middle Aged
  • Suppositories
  • Vagina/metabolism*
  • Vaginal Creams, Foams and Jellies

Substances:
  • Suppositories
  • Vaginal Creams, Foams and Jellies
  • Estriol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone

PMID: 6421082 [PubMed - indexed for MEDLINE]


 Display  Show